TD Cowen Downgrades Oak Street Health (OSH) to Market Perform (correction)

TD Cowen analyst Gary Taylor downgraded Oak Street Health (NYSE: OSH) from Outperform to Market Perform with a price target of $39.00 (from $34.00).

The analyst comments "In a bit of housekeeping, we are downgrading OSH from Outperform to Market Perform. Our price target moves from $34 to the CVS acquisition price of $39. While there are material moving parts for 2024, the net impact is only modest changes to our model; changing 2023-25 adjusted EBITDA losses from (-$255)/(-158)/(-8m) to (-$255)/(-149)/(-2m), respectively."

For an analyst ratings summary and ratings history on Oak Street Health click here. For more ratings news on Oak Street Health click here.

Shares of Oak Street Health closed at $35.24 yesterday.

You May Also Be Interested In

• Marvell (MRVL) PT Raised to $225 at TD Cowen
• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
• Freedom Broker Downgrades Flexsteel (FLXS) to Hold